These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8079828)

  • 1. Interleukin-1 beta, plasminogen activator and inhibitor of plasminogen activator in synovial fluid of rheumatoid arthritis, psoriatic arthritis and osteoarthritis.
    Pianon M; Punzi L; Stefani MP; Bertazzolo N; Michelotto M; Finco B; Gambari PF
    Agents Actions; 1994 Mar; 41(1-2):88-9. PubMed ID: 8079828
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis.
    Saxne T; Lecander I; Geborek P
    J Rheumatol; 1993 Jan; 20(1):91-6. PubMed ID: 8441174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
    Ronday HK; Smits HH; Van Muijen GN; Pruszczynski MS; Dolhain RJ; Van Langelaan EJ; Breedveld FC; Verheijen JH
    Br J Rheumatol; 1996 May; 35(5):416-23. PubMed ID: 8646430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
    Chu SC; Yang SF; Lue KH; Hsieh YS; Hsiao TY; Lu KH
    J Rheumatol; 2006 Feb; 33(2):311-7. PubMed ID: 16465663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-traumatic plasminogenesis in intraarticular exudate in the knee joint.
    Rość D; Powierza W; Zastawna E; Drewniak W; Michalski A; Kotschy M
    Med Sci Monit; 2002 May; 8(5):CR371-8. PubMed ID: 12011780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
    Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC
    Thromb Haemost; 1992 Aug; 68(2):180-4. PubMed ID: 1412164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevations in synovial fluid plasminogen activator in patients with rheumatoid arthritis.
    Mochan E; Uhl J
    J Rheumatol; 1984 Apr; 11(2):123-8. PubMed ID: 6427461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply to Xie et al. about the article "Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis".
    Talabot-Ayer D; Gabay C; Palmer G
    Joint Bone Spine; 2013 Jan; 80(1):117-8. PubMed ID: 23182161
    [No Abstract]   [Full Text] [Related]  

  • 9. [Detection and significance of plasminogen activator inhibitor in synovial tissue, synovial fluid and plasma from patients with rheumatoid arthritis].
    Yang C; Huang F
    Zhonghua Nei Ke Za Zhi; 2000 Oct; 39(10):690-3. PubMed ID: 11374178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationships between interleukin (IL)-1, IL-6 and IL-8 in synovial fluid of various arthropathies.
    Bertazzolo N; Punzi L; Stefani MP; Cesaro G; Pianon M; Finco B; Todesco S
    Agents Actions; 1994 Mar; 41(1-2):90-2. PubMed ID: 8079829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
    Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
    J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of IL-33 in rheumatoid arthritis: a comment about the article by Talabot-Ayer D, et al., "Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis", Joint Bone Spine 2012;79:32-7.
    Xie Q; Wang SC; Zhong J; Li J
    Joint Bone Spine; 2013 Jan; 80(1):116-7. PubMed ID: 23237993
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium.
    Pelletier JP; McCollum R; Cloutier JM; Martel-Pelletier J
    Br J Rheumatol; 1992; 31 Suppl 1():19-26. PubMed ID: 1555050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan catabolism in synovial fluid of various arthropathies and its relationship with inflammatory cytokines.
    Bertazzo A; Punzi L; Bertazzolo N; Pianon M; Pozzuoli A; Costa CV; Allegri G
    Adv Exp Med Biol; 1999; 467():565-70. PubMed ID: 10721101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlation with the PA/plasmin system in septic arthritis of the knee.
    Hsieh YS; Yang SF; Lue KH; Lu KH
    Clin Orthop Relat Res; 2006 Jun; 447():172-8. PubMed ID: 16505706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator in synovial fluid from patients with rheumatoid arthritis.
    Kikuchi H; Tanaka S; Matsuo O
    J Rheumatol; 1987 Jun; 14(3):439-45. PubMed ID: 3625626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of tissue kallikrein and alpha 1-antitrypsin-tissue kallikrein complexes in synovial fluid of patients with rheumatoid, osteo and psoriatic arthritis.
    Rahman MM; Worthy K; Elson CJ; Dieppe PA; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 3)():389-96. PubMed ID: 1462872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.
    Hornum L; Hansen AJ; Tornehave D; Fjording MS; Colmenero P; Wätjen IF; Søe Nielsen NH; Bliddal H; Bartels EM
    PLoS One; 2017; 12(12):e0189017. PubMed ID: 29220376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble E-selectin is increased in inflammatory synovial fluid.
    Carson CW; Beall LD; Hunder GG; Johnson CM; Newman W
    J Rheumatol; 1994 Apr; 21(4):605-11. PubMed ID: 7518520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.